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ABSTRACT
Objective: The present investigation was to evaluate the anticonvulsant potential of three different extracts of roots of Premna herbacea (Roxb.) in 
mice. The preclinical screening models such as isoniazid (INH)- and strychnine (STR)-induced convulsion were selected for the study.
Methods: The three different extracts of P. herbacea, i.e., ethanolic (PHE), petroleum ether (PHP), and chloroform (PHC) were prepared as per standard 
procedures and evaluated at three different doses (100, 200, and 400 mg/kg) and screened with above-mentioned INH and STR-induced convulsions.
Results: In INH model, PHC 200 mg/kg and 400 mg/kg showed dose-dependent delay in onset of convulsion (p<0.05 and p<0.01) along with 
protection of 33.33% of mice. The PHP 400 mg/kg also showed a significant delay in the onset of convulsion (p<0.05) along with protection of 16.66% 
of mice. In STR-induced model, none of the extracts was effective to delay the onset of convulsion; however, PHC 400 mg/kg protected 16.66% of mice.
Conclusion: The results confirmed dose-dependent anticonvulsant activity of P. herbacea PHC in INH-induced convulsions.
Keywords: Anticonvulsant, P. herbacea root extract, Strychnine, Isoniazid.
INTRODUCTION
Epilepsy is the disorder of the brain characterized by recurrent seizure 
of cerebral origin [1]. It is the second most common chronic neurological 
condition observed worldwide [2]. It affects approximately 1% of 
population which results in 3% of cumulative incidences [3,4].
The prevalence of epilepsy is higher in the developing countries such 
as India than developed countries [5]. Despite the availability of a large 
number of antiepileptic drugs in modern medicine, approximately 
30% of patients show poor response to the therapy, especially long-
term administration leading to recurrence [6,7]. High-cost, wide 
range of untoward effect, and development of tolerance are few other 
limitations [8]. Hence, search is continued to develop newer, more 
effective, and safe anticonvulsant agent.
Medicinal plant with traditional claim and being used since long has 
become the preferred target for development if an ideal drug [9]. 
Inherently margin, better effect, and wider safety on complaints with 
complex pathogenesis mostly due to the synergistic action of multiple 
phytoconstituents which increase advantages of medicinal plants [10].
As per literature survey, Premna herbacea is an important medicinal 
plant traditionally claimed for its usefulness in a variety of conditions 
including epilepsy. Further, its claim as an analgesic, anti-inflammatory, 
and antiulcer has been validated scientifically [11,12]. The roots of 
P. herbacea have been claimed to be useful in convulsions, however, yet 
not documented scientifically [13]. Hence, it was thought worthwhile to 
study the anticonvulsant activity of P. herbacea in mice to confirm the 
previous claim and its scientific documentation suggesting its potential 
anticonvulsant activity with lesser side effects.
MATERIALS AND METHODS
Preparation of extracts
The entire plant of P. herbacea (Roxb.) was collected from the Southern 
Ghats region and authenticated by Dr. K. Madhawa Chetty, at Shri 
Venkateswara University, Tirupati. The roots of the collected plants 
were carefully separated shade-dried and powdered. This powder was 
passed through a sieve (No. 40) and then subjected to extraction using 
Soxhlet apparatus with 70% ethanol (100 g in 500 mL), petroleum 
ether and chloroform at a temperature <20°C. After filtration, dark 
brown extract was evaporated at 50°C [14].
Animals
Swiss albino mice (18–25 g) of either sex were procured from M/s. 
National Toxicological Center, after obtaining the approval of the 
Institutional Animal Ethics Committee (RP-19/1516). The mice were 
acclimatized to the laboratory environment, provided with standard 
pellet diet and water ad libitum.
Drugs and chemicals
Pentylenetetrazol was purchased from Sigma, St. Louis, USA, isoniazid 
(INH) and strychnine (STR) from Sigma, St. Louis, USA, and diazepam 
from Ranbaxy, India. All chemicals and drugs were made available by 
local vendor.
Statistical analysis and calculations
Results were expressed as mean ± standard error. Statistical analysis 
was performed using one-way analysis of variance followed by 
Dunnett’s test. P <0.05 was considered as statistically significant.
Methods
Preliminary phytochemical analysis
Preliminary phytochemical analysis of all three extracts was 
carried out using established methods to record the presence of 
phytochemicals [15].
Determination of acute toxicity study (LD50)
The acute toxicity for all three extracts was performed as per the OECD 
guideline no 423 [16].
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Anticonvulsant activity of INH-induced convulsions
The 66 pre-selected mice of either sex (18–22g) were divided into 
eleven groups each consisting six mice. All these mice were subjected 
to respective treatment as mentioned in Table 1., for the period of 7 
days. On the 7th day 60 min after dosing, all mice were subjected 
to intraperitoneal injection of INH (300 mg/kg), and the onset of 
convulsion and percentage protection were recorded and compared 
against vehicle-treated control mice. Diazepam (5 mg/kg) was used as 
a reference standard [17,18,19].
Anticonvulsant activity of STR-induced convulsions
66 pre-selected mice of either sex (18-22 g) were divided into eleven 
groups each consisting six mice. All these mice were subjected to 
respective treatment as mentioned in Table 2., for the period of 7 
days. On the 7th day 60 min after dosing, all mice were subjected to 
intraperitoneal injection of STR (2 mg/kg), and the onset of convulsion 
and percentage protection of mice were recorded and compared 
against vehicle-treated control mice. Diazepam (5 mg/kg) was used as 
a reference standard [19,20].
RESULTS
Preliminary phytochemical analysis
The preliminary phytochemical analysis revealed the prominent 
presence of steroids, glycosides, and saponins which is biologically 
important. A detail analysis is tabulated in Table 3.
Acute oral toxicity study
The study reported that all three extracts are devoid of any toxicity as 
no mortality is reported at a dose of 2000 mg/kg.
Anticonvulsant activity
INH-induced convulsions
Intraperitoneal injection of INH is used to induce convulsions in 
all the mice. The vehicle-treated control group mice showed the 
onset of convulsions at 1224.68±18.122 s which was significantly 
delayed 1304.31±20.26 s by petroleum ether of P. herbacea (PHP) 
400 mg/kg. The chloroform extract of P. herbacea (PHC) 200 mg/kg 
and 400 mg/kg doses show dose-dependent delay to 1300.54±10.98 
s and 1350.89±21.86 s, respectively. However, PHC 200 mg/kg and 
400 mg/kg was exponent toward percentage protection of animals and 
protected 16.66 % of mice.
The Ethanolic extract of P. herbacea (PHE) 400 mg/kg also protected 
16.66% of mice. The reference standard diazepam was the most 
effective in delaying the onset of convulsions 1488.61±21.96 s and 
protecting the mice (83.33%)
STR-induced convulsions
Subcutaneous administration of STR induced convulsions in all mice. 
None of extracts could significantly delay the onset of convulsion as 
compared to vehicle-treated mice; however, PHC 400 mg/kg protected 
16.66% of mice. Reference standard diazepam significantly delayed the 
onset of convulsions to 222.57±4.85 s as compared to vehicle-treated 
control mice, i.e., 141.16±03.34 s and protected 83.33% s of mice.
DISCUSSION
Considering the adverse effects of the drugs used in the treatment 
of convulsion [21,22] and since primitive times, humans have used 
natural products, such as plants, animals, microbes, and aquatic 
organisms, in medicines to improve and treat diseases and disorders. 
According to the records, the human used plants as medicines from 
ancient times at least 60,000 years back [23,24]. Many traditional 
medicines originated from the plants have been used in the treatment 
of CNS disorders in the Indian Traditional Medicine; however, very few 
Table 1: Effects of Premna herbacea extracts on INH-induced convulsions
Groups Treatment Onset of convulsion (s) (mean±SEM) Number of mice survived after 24 h
I Control distilled water 10 ml/kg 1224.68±18.122 0
II Diazepam 5 mg/kg 1488.61±21.96 5
III PHE 100 mg/kg 1219.67±26.13 0
IV PHE 200 mg/kg 1203.30±12.92 0
V PHE 400 mg/kg 1201.69±20.22 1
VI PHP 100 mg/kg 1192.49±10.54 0
VII PHP 200 mg/kg 1223.00±20.91 0
VIII PHP 400 mg/kg 1304.31±20.26* 1
IX PHC 100 mg/kg 1201.77±13.94 0
X PHC 200 mg/kg 1304.54±10.98* 2
XI PHC 400 mg/kg 1350.89±21.86 ** 2
The values are represented as mean±SEM (n=6). SEM: Standard error mean, P. herbecea: Premna herbecea, PHE: Ethanolic extract of P. herbacea, PHP: Petroleum ether 
extract of P. herbacea, PHC: Chloroform extract of P. herbacea, INH: Isoniazid
Table 2: Effects of Premna herbacea on STR-induced convulsions




I Distilled water 10 ml/kg 154.08±03.23 0
II Diazepam 5 mg/kg 316.89±09.63 83.33
III PHE 100 mg/kg 154.51±03.30 0
IV PHE 200 mg/kg 153.99±03.04 0
V PHE 400 mg/kg 155.02±02.83 0
VI PHP 100 mg/kg 152.73±03.13 0
VII PHP 200 mg/kg 151.92±02.06 0
VIII PHP 400 mg/kg 156.37±03.76 0
IX PHC 100 mg/kg 157.37±04.17 0
X PHC 200 mg/kg 155.88±03.49 0
XI PHC 400 mg/kg 157.24±03.32 16.66
The values are represented as mean±SEM (n=6). SEM: Standard error 
mean, P. herbecea: Premna herbecea, PHE: Ethanolic extract of P. herbacea, 
PHP: Petroleum ether extract of P. herbacea, PHC: Chloroform extract of 
P. herbacea, STR: Strychnine
Table 3: Preliminary phytochemical analysis of P. herbecea
Phytochemical PHE PHP PHC
Carbohydrates Carbohydrates ++ - -
Protein + - +
Amino acids - - -
Fats and oils - - -
Steroids + + ++
Volatile oils - - +
Cardiac glycosides + - -
Anthraquinone glycosides - - +
Cyanogenetic glycosides - - -
Coumarin glycosides + - +
Saponins + - -
Flavonoids - - -
Alkaloids - - -
Tannins and phenolic compounds + + +
P. herbecea: Premna herbecea, PHE: Ethanolic extract of P. herbacea, 
PHP: Petroleum ether extract of P. herbacea, PHC: Chloroform extract of 
P. herbacea
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of these plants have been evaluated preclinically to prove the rational 
use [25,26].
The rich and diverse plant sources in India are likely to provide 
effective drugs [27]. One of the best approaches in the search 
for drugs from plant resources is the selection of plant-based on 
ethnomedical leads [28]. Plants contain numerous constituents known 
as phytochemicals with varied medicinal values. Moreover, the claims 
made in the traditional literature are indistinguishable [29]. Hence, 
scientific validation of these claims is necessary to make therapy more 
effective and patient-friendly. The present study has been conducted 
to coordinate the traditional claim, experimental observations, and 
role of phytochemicals to establish its close relationship toward the 
actual therapeutic outcome. In the present investigation, preliminary 
phytochemical analysis of PHE showed the presence of glycosides, 
flavonoids, tannins, and steroids, while PHP reported prominent 
presence of steroids and proteins; steroids, anthraquinone, and 
coumarin glycosides were found in PHC. The earlier scientific studies 
have revealed that most of these phytochemicals are chiefly responsible 
for the pharmacological actions [30-32] and thereby suggested worth to 
explore the traditional claims [33]. Toxicity is one of the most important 
aspects of any medication to govern the extent of therapeutic utility 
[34]. Since preliminary phytochemical results gave indication of further 
pharmacological screening, it becomes mandatory to evaluate these 
extracts for their toxicity profile and confirm its safety [35]. The acute 
oral toxicity study of PHE, PHP, and PHC revealed that all these extracts 
are safe to be used as drug. The results of acute oral toxicity study 
further suggested that these extracts can be screened preclinically 
for validation of its traditional claim in accordance with the methods 
mentioned in previously published reports. Further, the pilot study and 
dose range were found to be effective without any toxic outcome in 
earlier published reports, and three different doses, i.e., 100, 200, and 
400 mg/kg for each extract were selected for anticonvulsant activity 
[35]. The findings of these studies suggest that PHC possess significant 
anticonvulsant activity against INH-induced convulsions. Since INH 
interferes with GABA synthesis through inhibition of glutamic acid 
decarboxylase resulting into rapid depletion of GABA which causes the 
potentiation of GABA transmission or prevention of its depletion is the 
probable mechanism of action. Diazepam is widely accepted for this 
type of epilepsy which has sedation and tolerance as major limitations. 
In the pilot study and during regular pretreatment, none of the extract 
of PH showed any sign of sedation which perhaps could be the major 
advantage of it over diazepam and outcome of this study. Saponin, 
steroid, and flavonoids are prominently responsible for anticonvulsant 
activity. The preliminary phytochemical analysis showed the presence 
of steroids in PHC only, while saponin was present in both PHE and PHP, 
suggesting major role of steroid in action. Since saponin was present, 
PHP 400 mg/kg and PHE 400 mg/kg were found to be effective in 
delaying onset and protecting mice, respectively. STR induces seizures 
by competitively antagonizing inhibitory amino acid glycine.
In STR model, none of the extracts showed any significant effect, 
suggesting non-involvement glycine-mediated inhibition in its 
anticonvulsant activity.
CONCLUSION
It can be concluded form the study that chloroform extract of PH 
possesses anticonvulsant activity against INH-induced convulsion. This 
effect may be due to the prevention of GABA depletion and potentiation 
of GABA and attributed to the steroidal content of the extract.
However, further detail study is required to establish the precise 
mechanism of action and role of exact phytoconstituent.
ACKNOWLEDGMENT
Authors are thankful to the National Toxicological Institute for the 
provision of facility to carry out experiments as well as PRIST University 
for their valuable support.
AUTHORS’ CONTRIBUTION
Performed collection of sample, extraction, analysis, and statistical 
analysis of data and wrote the manuscript. The second author 
supervised the progress of work and helped in the evaluation of the 
manuscript and its language corrections.
CONFLICTS OF INTEREST
Authors declare no conflicts of interest.
REFERENCES
1. Delgado-Escueta AV, Treiman DM, Walsh GO. The treatable epilepsies. 
N Engl J Med 1983;308:1508-14.
2. England MJ, Liverman CT, Schultz AM, Strawbridge LM. Epilepsy 
Across the Spectrum: Promoting Health and Understanding. 
Washington (DC): National Academies Press (US); 2012.
3. Rout SK, Kar DM. A review on antiepileptic agents, current research 
and future prospectus on conventional and traditional drugs. Int J 
Pharm Sci Rev Res 2010;3:19-3.
4. Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan CT. Epidemiology, 
etiology and clinical management of epilepsy in Asia: A systematic 
review. Lancet Neurol 2007;6:533-43.
5. Shridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. 
Epilepsia 1999;40:631-6.
6. Ezekiel I, Mabrouk MA, Ayo JO, Goji AD, Okpanachi AO, 
Mohammed A, et al. Study of the effect of hydro-ethanolic extract of 
Commiphora Africana (stem-bark) on sleeping time and convulsion in 
mice. Asian J Med Sci 2010;2:85-8.
7. Joy PP, Thomas J, Mathew S, Skaria BP. Medicinal Plants Tropical 
Horticulture. Vol. 2. Calcutta: Naya Prokashan; 2001.
8. Maiha BB, Magaji MG, Yaro AH, Ahemd ST, Hamza AH, Magaji RA. 
Anticonvulsant studies on Cochlospermum tinctorium and Paullinia 
piñata extracts in laboratory animals. Nigern J Pharm Sci 2009;8:102-8.
9. Wannang NN, Anuka JA, Kwanashie HO, Gyang SS, Auta A. 
Antiseizure activity of the aqueous leaf extract of Solanum nigrum linn 
(solanaceae) in experimental animal. Afr Health Sci 2008;8:74-9.
10. Suresh K. Plants and plant products with potential anticonvulsant 
activity—a review. Pharmacogn Commun 2012;2:3-99.
11. Moldenke HN. A sixth summary of the Verbenaceae, avicenniaceae, 
Stilbaceae, chloanthaceae, symphoremaceae, nyctanthaceae and 
Eriocaulaceae of the world as to valid taxa, geographic distribution and 
synonymy. Phytol Mem 1980;2:284-5.
12. Thai Plant Names Tem Smitinand. The Forest Herbarium. Bangkok: 
Royal Forest Department Revised Edition; 2001. p. 810.
13. Nadkarni AK. Indian Material Medica. New Delhi: Popular Prakashan; 
1985. p. 1008.
14. Lolita T, Zanda K, Galoburda R. Comparison of different solvents 
and extraction methods for isolation of phenolic compounds from 
horseradish roots (Armoracia rusticana). Int J Biol Biomol Agric Food 
Biotechnol Eng 2012;6:236-41.
15. Khandelwal KR. Practical Pharmacognocy. Mumbai: Pragati Books 
Pvt. Ltd.; 2008.
16. OECD. Guideline on Acute Oral Toxicity, Environmental Health and 
Safety Monograph Series on Testing and Adjustment No 423; 2001.
17. Vogel HG, Gang HW. Drug Discovery and Evaluation Pharmacological 
Assays. 4th ed. New York: Springer-Verlag Berlin Heidelberg; 2002.
18. Nandakumar J, Manoj GT. Evaluation of cyclic nucleotide 
phosphodiesterase III inhibitors in animal models of epilepsy. Biomed 
Res 2008;19:13-7.
19. Alice AL, Elvin JB. Glycine potentiates strychinine-induced 
convulsions: Role of NMDA receptoe. J Neurosci 1988;8:3823-26.
20. Curtis DR, Game CJ, Lodge D. Benzodiazepines and central glycine 
receptors. Br J Pharm 1976;56:307-11.
21. Gupta YK, Malhotra J. Adenosinergic system as an endogenous 
anticonvulsant mechanism. J Physilol Pharmacol 1997;41:329-43.
22. Henry D, Sylvia A, Chidambaranathan S, Nirmala P. A prospective 
study of drug utilization pattern of anti-epileptic drugs and their adverse 
effects in a tertiary care hospital. Int J Curr Pharm Res 2017;9:42-5.
23. Shi QW, Li LG, Huo CH, Zhang ML, Wang YF. Study on natural 
medicinal chemistry and new drug development. Chin Tradit Herb 
Drugs 2010;41:1583-9.
24. Fabricant DS, Farnsworth NR. The value of plants used in traditional 
medicine for drug discovery. Environ Health Perspect 2001;109:69-75.
25. Mukherjee DG, Dey CD. Clinical trial on Brahmi. India J Exp Med Sci 
436
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 433-436
 Chimbalkar and Vyawahare 
1996;10:5-8.
26. Madhavi E, Gopala RK, Ruckmani A, Umar D. Evaluation of 
antiepileptic activity of ethanolic extract of Azima tetracantha root in 
mice. Int J Curr Pharm Res 2016;8:76-9.
27. Dwyer AV, Whitten DL, Hawrelak JA. Herbal medicines, other than St. 
John’s Wort, in the treatment of depression: A systematic review. Altern 
Med Rev 2011;16:40-9.
28. Katiyar C, Gupta A, Kanjilal S, Katiyar S. Drug discovery from plant 
sources: An integrated approach. Ayu 2012;33:10.
29. Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal 
plants and natural products. Indian J Pharmacol 2000;32:S81-118.
30. Chaulya NC, Haldar PK, Mukherjee A, Khanra R, Chakraborty A. 
Anticonvulsnt acivity of methanolic extract of Rhizomes of Cyperus 
tegetum Roxb. J Pharm Sci Tec 2011;1:1-5.
31. Nimbal SK, Vekatrao N, Basaavraj P, Shalam, Ladde S. Evaluation 
of anticonvulsant activity of alcoholic extract of Beninkasa hispida 
(Thunb) cogn. Fruit extracts. Int Res J Pharm 2011;2:166-8.
32. Atigari DV, Gundamaraju R, Sabbithi S, Chaitanya KB, Ramesh C. 
Evaluation of antiepileptic activity of methnolic extract of Celastrus 
paniculatus, Wild whole plant in rodents. Int J Pharm Phytopharmacol 
Res 2012;2:20-5.
33. Gogte HN. Ayurvedic Pharmacology and Therapeutic uses of Medicinal 
Plant. New Delhi: Drvyagunavidnyana, Chaukhamba Publication; 
2009. p. 450-3.
34. Rang HP, Ritter JM, Flower RJ, Bookmark G. Pharmacology. 5th ed. 
London: Churchill Livingstone; 2003.
35. Thirumalai D, Paridhavi M, Gowtham M. Evaluation of physiochemical, 
pharmacognostical and phytochemical parameters of Premna herbacea. 
Asian J Pharm Clin Res 2013;6:1173-81.
